Label-invariant models for the analysis of meta-epidemiological data

Statistics in Medicine

Volumn 37, Issue 1, 2018, Pages 60-70

  Rhodes, K M ^a   Mawdsley, D ^b   Turner, R M ^a,c   Jones, H E ^d   Savovic J ^d,e   Higgins, J P T ^d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bayesian methods; Cochrane; heterogeneity; meta epidemiology; randomised trials

Indexed keywords

CLINICAL TRIAL (TOPIC); DATA ANALYSIS; FEMALE; HUMAN; MALE; META ANALYSIS; SAMPLE SIZE; BIOSTATISTICS; EPIDEMIOLOGY; META ANALYSIS (TOPIC); MULTIVARIATE ANALYSIS; PROCEDURES; STATISTICAL ANALYSIS; STATISTICAL BIAS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

BIAS; BIOSTATISTICS; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; EPIDEMIOLOGIC STUDIES; HUMANS; META-ANALYSIS AS TOPIC; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; SAMPLE SIZE;

EID: 85030107203     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.7491     Document Type: Article

References (18)

1. Savović J, Jones H, Altman D, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technol Assess. 2012;16(35):1-82.
2. Welton NJ, Ades AE, Carlin JB, Altman DG, Sterne JAC. Models for potentially biased evidence in meta-analysis using empirically based priors. J R Stat Soc A Stat Soc. 2009;172(1):119-136.
3. Giraudeau B, Higgins JPT, Tavernier E, Trinquart L. Sample size calculation for meta-epidemiological studies. Statist Med. 2016;35(2):239-250.
4. Lambert PC, Sutton AJ, Burton PR, Abrams KR, Jones DR. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Statist Med. 2005;24(15):2401-2428.
5. Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane database of systematic reviews. Int J Epidemiol. 2012;41(3):818-827.
6. Savović J, Turner RM, Mawdsley D, Beynon R, Jones HE, Higgins JPT, Sterne JAC. Influence of Cochrane authors' assessments of risk of bias on intervention effect estimates from randomized controlled trials included in Cochrane reviews: a meta-epidemiologic study. Submitted for publication 2016.
7. Higgins JPT, Altman DG, Goetzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
8. Dechartres A, Trinquart L, Boutron I, Ravaud P. Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ. 2013;346:f2304.
9. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Chichester: John Wiley & Sons, Ltd; 2003.
10. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS – a Bayesian modelling framework: concepts, structure, and extensibility. Statistics and Computing. 2000;10(4):325-337.
11. Brooks SP, Gelman A. General methods for monitoring convergence of iterative simulations. Journal of Computational and Graphical Statistics. 1998;7(4):434-455.
12. Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Series B Stat Methodology. 2002;64(4):583-639.
13. Spiegelhalter DJ, Best NG, Carlin BP, Linde A. The deviance information criterion: 12 years on. J R Stat Soc Series B Stat Methodology. 2014;76(3):485-493.
14. Welton NJ, Ades AE. A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence. J R Stat Soc Ser C Appl Stat. 2005;54(2):385-404.
15. Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ. 2010;340:c723.
16. Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. Journal of the Royal Statistical Society, Series A. 2009;172:137-159.
17. Nüesch E, Trelle S, Reichenbach S, et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ. 2010;341:c3515.
18. Turner RM, Bird SM, Higgins JPT. The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS One. 2013;8(3):e59202.